Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy.

Abstract

The complete regression of residual tumors after photothermal therapy (PTT) depends on the activation and recognition of the immune system. However, the inevitable local inflammation after PTT in residual tumor recruits abundant abnormal immune cells, especially the tumor-associated macrophages (TAMs) which further promote immune escape and survival of the remaining tumor cells, resulting in the tumor recurrence and progression. To solve this problem, herein we explored biomimetic nanoparticles carrying repolarization agent of TAMs to remodel the post-PTT inflammatory microenvironment. The polydopamine nanoparticles were used simultaneously as photothermal transduction agents to ablate tumor cells and the delivery vehicles for TMP195 which can repolarize the M2-like TAMs into an antitumor phenotype. In addition, a biomimetic decoration of macrophage membrane coating was designed to endow nanoparticles the ability to actively target the tumor site after PTT mediated by inflammation-mediated chemotaxis. In the breast tumor model, these biomimetic nanoparticles with immune-modulating ability significantly elevated the levels of M1-like TAMs, ultimately resulting in a tumor-elimination rate of 60%, increased from 10% after PTT. This synergistic treatment strategy of PTT and TAMs repolarization provides a promising approach to address the deteriorated tumor microenvironment after PTT and proposes a more effective way for combinational treatment option in clinic.

• Authors: Yale Yue, Fenfen Li, Yao Li, Yazhou Wang, Xinjing Guo, Zhaoxia Cheng, Nan Li, Xiaotu Ma, Guangjun Nie, Xiao Zhao
• Journal: ACS nano (ACS Nano) Vol. 15 Issue 9 Pg. 15166-15179 (09 28 2021) ISSN: 1936-086X [Electronic] United States
• PMID: 34469109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Biomimetics
• Nanoparticles
• Photothermal Therapy
• Tumor-Associated Macrophages